Mortality based on the presenting electrocardiogram in patients with myocardial infarction in the troponin era

Michael C Kontos1, Brett D Roberts, James L Tatum

  • 1Department of Internal Medicine, Cardiology Division, Virginia Commonwealth University, Richmond, Virginia, USA. mkontos@mcvh-vcu.edu

Insights

Initial electrocardiogram (ECG) findings in myocardial infarction (MI) impact outcomes. Even without ST-elevation, specific ECG patterns indicate higher mortality risk in MI patients.

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Limited data exists on short-term mortality for myocardial infarction (MI) patients with non-ischemic initial electrocardiogram (ECG) findings.
  • Previous studies often excluded patients with normal or nonspecific ECGs, leaving their outcomes unclear, particularly in the current troponin era.

Purpose of the Study:

  • To investigate the 30-day mortality rates in patients diagnosed with MI based on initial ECG classifications.
  • To assess the relationship between various initial ECG findings and MI size, as estimated by cardiac biomarker levels.

Main Methods:

  • 1641 consecutive patients diagnosed with MI using troponin I (TnI) were classified into 8 ECG groups.
  • MI size was estimated using creatine kinase-MB (CK-MB) levels.
  • 30-day mortality was assessed for each ECG group.

Main Results:

  • ST-elevation MI constituted only 22% of cases, with larger infarct sizes.
  • Most MIs (78%) had non-ST-elevation ECGs, with smaller infarct sizes; 1/3 diagnosed by TnI elevation alone.
  • High-risk ECG groups (ST-elevation, ischemia, LBBB) had >9% mortality, while lower-risk groups averaged 6% mortality (P < .001).

Conclusions:

  • ECG findings beyond ischemia predict poor outcomes in MI patients.
  • All patients diagnosed with MI should be considered at significant risk, regardless of initial ECG presentation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...